Cancer myths and misconceptions

“You know, sometimes cancer isn’t really cancer.”

The first time I heard this, just a few years after I’d completed my medical training, I was shocked. But it’s true. The line between cancer and benign isn’t always black and white.

Cancer myths

Myth: Cancer Is Cancer

Malignant (cancerous) cells have features that are generally unmistakable: They grow unchecked, have unusual shapes, have an abnormal number of nuclei (where the DNA is), and can spread to places they don’t belong (metastasize).

Pathologists — specialists who examine cells under the microscope — train extensively to tell the difference between malignant and normal cells. But even experienced pathologists find it difficult to make a sure diagnosis of cancer.

Unless the pathology findings are clear-cut, a cancer diagnosis isn’t always a simple yes or no. Non-cancerous cells can sometimes look like cancer cells. For example, a nearby infection may cause the cells in a lymph node to change in appearance. These “reactive” changes can be confused with changes suggestive of cancer.

The Pap test is a good example of how abnormal cells can blur the line between normal and cancerous. For a Pap test, cervical cells are collected during a pelvic exam and then examined by a pathologist under a microscope. There is widespread agreement that this test is worth having because it helps doctors diagnose cervical cancer and pre-cancerous changes while they are curable. Yet, the range of abnormal test results makes clear that the search for cancer is often full of uncertainty. Here are a few of the possible test results:

  • Abnormal but of no definite importance – A Pap test report may read “ASC-US” which stands for “atypical squamous cells of undetermined significance.” This result may occur after a vaginal infection or human papilloma virus infection (HPV). It usually requires only treatment of the infection (if one is present) and repeating the Pap test.
  • Abnormal and potentially precancerous – A reading of “HSIL,” which means high-grade squamous intraepithelial lesion, indicates that the cells are markedly different from normal cells and that there is a significant risk that they will progress to an invasive cancer. This finding usually leads doctors to recommend colposcopy (a more detailed examination of the cervix) or surgery to remove the abnormal tissue. Similarly, “ASC-H” (atypical squamous cells, high-grade), “AGC” (atypical glandular cells), and “high grade dysplasia” are findings of uncertain importance that may indicate a higher risk of cervical cancer.
  • Cancer – Markedly abnormal cells collected during a Pap test may be malignant (cancerous), requiring colposcopy and surgery to remove the area of abnormal cells.

Women who follow the recommended schedule for Pap test are likely at some point to have one of the “pre-cancerous” abnormalities, even when no cancer is present. The uncertainty and occasional difference of agreement between pathologists who read Pap tests are a source of confusion, frustration, and, when a cancer is missed, tragedy.

When is cancer not really cancer? The clearest example is when a biopsy is reviewed and the original cancer diagnosis is “overturned.” This is rare though.

Other Cancer Myths and Misconceptions

Here are some other common misconceptions about cancer that I often hear from my patients:

  • Cancer is one disease. When people talk about a cure for cancer, there’s an implication that it’s a single illness. In fact, we should think of cancer as many different diseases, with different causes, preventive measures and treatments. It’s highly unlikely that a single treatment will cure all types of cancer. And certain cancers are already curable. Many types of skin cancers, for example, are curable just by removing them. Others types, such as cancer of the pancreas, are almost never cured.
  • A biopsy can always diagnose cancer. Biopsy is almost always the best way to diagnose cancer, but it’s not as perfect as you might think. If tissue is straddling the fine line between cancerous and non-cancerous, a biopsy may not be diagnostic. In the future, it’s likely we’ll have other ways to predict or diagnose cancer, such as the presence of proteins on the surface of cancer cells, genetic mutations and the appearance of tumors on certain imaging tests. None of these, however, are routinely better than a biopsy at the present time.
  • Gather enough information and you’ll get your answer. Doctors seem to have an endless number of blood tests and imaging tests (such as X-rays, MRIs, and CT scans) to evaluate a person with a suspicion of cancer. Unfortunately, extensive testing is generally no match for a biopsy. However, an imaging test like a CT scan, can help the doctor insert a biopsy instrument safely to take a tissue sample.
  • A rising incidence of cancer is always a cause for concern. An increase in the number of new cancers could be due to better detection. And that’s a good thing! For example, the incidence of breast cancer can change based on how conscientious women are about getting a mammogram every year. And a recent increase in melanoma, the deadliest form of skin cancer, is likely due to an increase in the number of skin biopsies rather than an increase in the disease itself. In other words, because of how we measure rates of cancer, an increase in the number of cancer diagnoses is not always due to more cancer.
  • The prevalence of cancer is on the rise. It’s true that more people currently have cancer now than in the past. But at least two of the reasons for this are positive developments: People are living longer (and advanced age is a risk factor for cancer) and people with cancer are living longer after diagnosis. Better cancer care — and better medical care in general — have contributed to the rising number of people living with cancer. Finally, there are more people on the earth today than ever before and that plays a role as well: More people means more people with cancer. However, the actual risk of cancer is falling.
  • If you have cancer, it’s always best to know. There may be a philosophical debate on this one, but I believe there are times when it’s best not to know you have cancer. A good example is when a man has a slow-growing prostate cancer that poses no health threat. In fact, if a man lives long enough, there’s a good chance he’ll have prostate cancer but die of something else. Detection of these cancers only leads to unnecessary worry and, in some cases, treatments that have no real benefit but lots of side effects.

The Bottom Line

Cancer is a source of great fear, confusion and misconception. While cancer is actually many different diseases, these two facts should provide some measure of reassurance:

  • Modern medicine has achieved impressive advances in the fight against many types of cancer.
  • There is much you can do to reduce your cancer risk.

Fortunately, this bit of good news is no myth.

Copyright © 2008 by the Presidents and Fellows of Harvard College.

June 18th, 2008 | Leave a Comment

Cancer Drug Appears to Help With Aggressive MS

High doses of a drug used to fight cancer may reduce disease activity and disability in people with aggressive multiple sclerosis, results of a small trial suggest.

In relapsing-remitting MS, the most common type of the disease, patients experience periods of symptoms followed by stretches of symptom-free remission when they used the immunosuppressant drug cyclophosphamide.

In the two-year open label trial that included nine patients with aggressive relapsing-remitting MS, six men and three women with the average age of 35, received 50 milligrams per kilogram per day of cyclophosphamide intravenously for four consecutive days.

After an average of 23 months follow-up, the patients experienced an average 39.4 percent reduction in disability and an 87 percent improvement on scores of physical and mental function. MRI imaging showed a decrease in the average number of MS-related brain lesions, from 6.5 to 1.2 lesions.

“High-dose cyclophosphamide (sold commercially as Cytoxan or Neosar) induced a functional improvement in most of the patients we studied,” wrote lead author Chitra Krishnan of the Bloomberg School of Public Health at Johns Hopkins University in Baltimore, Md. “In many of those patients, the functional improvement was sustained through the length of the study (up to 24 months) despite the absence of any immunomodulatory therapies beyond the initial high-dose cyclophosphamide treatment,” she concluded.

The study was published online this week in the journal Archives of Neurology and was expected to be in the August print issue.

Cyclophosphamide has been used in combatting a number of cancers, including lymphomas, multiple myeloma, leukemia, mycosis fungoides, neuroblastoma, ovarian carcinoma, retinoblastoma and breast cancer. The drug affects the function of immune cells known as T and B cells.

Multiple sclerosis is an inflammatory disease in which the protective coating covering nerve cells degenerates. Autoimmune dysfunction — in which the body attacks itself — is believed to be linked with MS.

“This immunoablative regimen (an immune-related therapy involving the destruction of a cell population) of cyclophosphamide for patients with aggressive MS is worthy of further study and may be an alternative to bone marrow transplantation,” the study authors concluded.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about multiple sclerosis.

June 13th, 2008 | Leave a Comment

Winter vomiting virus

Winter vomiting virus
“Winter vomiting” is usually non-fatal, but dramatic

The winter vomiting virus causes unpleasant but non-fatal infections that last only a few days.
Even the elderly and frail are likely to make a full recovery after contracting the illness. Read More …

February 22nd, 2008 | Leave a Comment

Powered by WordPress | Blue Weed by Blog Oh! Blog | Entries (RSS) and Comments (RSS).